by Hugo C. Turner, Alison A. Bettis, Brian K. Chu et al.
Clin Infect Dis (2017) 64 (6): 728-735 – Published: 10 December 2016

8 pp. 1.6 MB
https://academic.oup.com/cid/article-pdf/64/6/728/10834156/ciw835.pdf

The authors found that both the preventive chemotherapy and hydrocele surgery provided under the Global Programme to Eliminate Lymphatic Filariasis (GPELF) are cost-effective and offer a very good investment in public health. These results clearly demonstrate the value and importance of continued investment in the GPELF and show that continued funding is justified and highly cost-effective.

(Visited 13 times, 1 visits today)
This entry was posted in Development Assistance, General, Other Infectious Diseases. Bookmark the permalink.
Facebook Auto Publish Powered By : XYZScripts.com
Get the latest issue of the NewsletterDownload